Preotact after a brEAK
Phase of Trial: Phase III
Latest Information Update: 25 Oct 2007
At a glance
- Drugs Parathyroid hormone (Primary)
- Indications Postmenopausal osteoporosis
- Focus Adverse reactions; Therapeutic Use
- Acronyms PEAK
- 25 Oct 2007 Preliminary results in the first 125 patients have been reported at ASBMR 2007.
- 24 Oct 2007 New trial record.